REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD

Takeda Pharmaceutical CoAnnouncement

29/11/2018 10:20

RNS Number : 9008I
Societe Generale SA
29 November 2018
 


FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION     
 



(a) Full name of discloser:


Société Générale S.A.




(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


 
 
 




(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical CO LTD




(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:








(e) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


28/11/2018       




(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES: Shire PLC
 



 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



Class of relevant security:
 


Ordinary




 
 


Interests


Short positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


1,931,611


0.25


7,776,693


0.99




(2) Cash-settled derivatives:
 


6,898,733


0.88


0


0.00




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


121,500


0.02


256,000


0.03




 
     TOTAL:


8,951,844


1.14


8,032,693


1.02



           
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:







 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales



Class of relevant security


Purchase/sale


Number of securities


Price per unit
JPY




Ordinary


Purchase


100


4236




Ordinary


Purchase


9,200


4200.924274




Ordinary


Purchase


500


4166




Ordinary


Purchase


800


4220




Ordinary


Purchase


600


4215




Ordinary


Purchase


900


4196




Ordinary


Purchase


500


4212




Ordinary


Purchase


600


4211




Ordinary


Purchase


500


4165




Ordinary


Purchase


500


4213




Ordinary


Purchase


600


4211




Ordinary


Purchase


1,000


4196




Ordinary


Purchase


500


4210




Ordinary


Purchase


600


4146




Ordinary


Purchase


1,100


4171




Ordinary


Purchase


1,100


4166




Ordinary


Purchase


1,100


4182




Ordinary


Purchase


200


4152




Ordinary


Purchase


1,100


4152




Ordinary


Purchase


1,100


4152




Ordinary


Purchase


1,100


4181




Ordinary


Purchase


100


4172




Ordinary


Purchase


100


4173




Ordinary


Purchase


300


4173




Ordinary


Purchase


100


4154




Ordinary


Purchase


100


4173




Ordinary


Purchase


200


4171




Ordinary


Purchase


100


4170




Ordinary


Purchase


1,100


4169




Ordinary


Purchase


100


4166




Ordinary


Purchase


100


4175




Ordinary


Purchase


1,100


4173




Ordinary


Purchase


400


4177




Ordinary


Purchase


100


4222




Ordinary


Purchase


800


4175




Ordinary


Purchase


1,100


4176




Ordinary


Purchase


500


4179




Ordinary


Purchase


800


4185




Ordinary


Purchase


1,100


4189




Ordinary


Purchase


200


4162




Ordinary


Purchase


200


4167




Ordinary


Purchase


400


4183




Ordinary


Purchase


1,100


4154




Ordinary


Purchase


300


4173




Ordinary


Purchase


600


4173




Ordinary


Purchase


1,100


4167




Ordinary


Purchase


1,300


4170




Ordinary


Purchase


500


4172




Ordinary


Purchase


1,100


4173




Ordinary


Purchase


1,100


4179




Ordinary


Purchase


1,100


4172




Ordinary


Purchase


1,100


4151




Ordinary


Purchase


500


4148




Ordinary


Purchase


800


4148




Ordinary


Purchase


800


4182




Ordinary


Purchase


700


4148




Ordinary


Purchase


100


4218




Ordinary


Purchase


500


4152




Ordinary


Purchase


100


4161




Ordinary


Purchase


300


4161




Ordinary


Purchase


300


4161




Ordinary


Purchase


400


4174




Ordinary


Purchase


100


4191




Ordinary


Purchase


100


4214




Ordinary


Purchase


100


4176




Ordinary


Purchase


100


4194




Ordinary


Purchase


400


4195




Ordinary


Purchase


200


4195




Ordinary


Purchase


2,500


4212




Ordinary


Purchase


700


4174




Ordinary


Purchase


400


4220




Ordinary


Purchase


500


4221




Ordinary


Purchase


300


4199




Ordinary


Purchase


500


4172




Ordinary


Purchase


2,500


4227




Ordinary


Purchase


100


4169




Ordinary


Purchase


1,200


4210




Ordinary


Purchase


2,500


4198




Ordinary


Purchase


100


4240




Ordinary


Purchase


2,500


4210




Ordinary


Purchase


1,400


4173




Ordinary


Purchase


1,500


4174




Ordinary


Purchase


1,400


4170




Ordinary


Purchase


800


4170




Ordinary


Purchase


100


4211




Ordinary


Purchase


200


4233




Ordinary


Purchase


200


4168




Ordinary


Purchase


100


4233




Ordinary


Purchase


1,500


4203




Ordinary


Purchase


2,500


4223




Ordinary


Purchase


1,900


4236




Ordinary


Purchase


500


4198




Ordinary


Purchase


300


4199




Ordinary


Purchase


200


4192




Ordinary


Purchase


19,600


4196.65




Ordinary


Purchase


85


4171




Ordinary


Sale


13,300


4236




Ordinary


Sale


1,600


4236




Ordinary


Sale


700


4178




Ordinary


Sale


600


4178




Ordinary


Sale


3,900


4236




Ordinary


Sale


400


4210




Ordinary


Sale


500


4161




Ordinary


Sale


1,100


4199




Ordinary


Sale


700


4170




Ordinary


Sale


1,100


4202




Ordinary


Sale


100


4202




Ordinary


Sale


1,100


4200




Ordinary


Sale


600


4199




Ordinary


Sale


100


4201




Ordinary


Sale


1,000


4201




Ordinary


Sale


1,100


4199




Ordinary


Sale


700


4174




Ordinary


Sale


1,100


4225




Ordinary


Sale


1,100


4206




Ordinary


Sale


200


4210




Ordinary


Sale


10,000


4236




Ordinary


Sale


100


4234.5




Ordinary


Sale


100


4174




Ordinary


Sale


100


4227.5




Ordinary


Sale


100


4172




Ordinary


Sale


800


4176.5




Ordinary


Sale


100


4173.5




Ordinary


Sale


900


4174




Ordinary


Sale


400


4170




Ordinary


Sale


400


4168.5




Ordinary


Sale


300


4169




Ordinary


Sale


100


4169




Ordinary


Sale


800


4169




Ordinary


Sale


300


4173




Ordinary


Sale


500


4175




Ordinary


Sale


200


4174.5




Ordinary


Sale


200


4229.5




Ordinary


Sale


200


4227.5




Ordinary


Sale


100


4229.5




Ordinary


Sale


100


4151.5




Ordinary


Sale


100


4174




Ordinary


Sale


400


4173




Ordinary


Sale


100


4167




Ordinary


Sale


100


4170




Ordinary


Sale


300


4170




Ordinary


Sale


200


4178




Ordinary


Sale


300


4239




Ordinary


Sale


14,000


4236




Ordinary


Sale


1,400


4236




Ordinary


Sale


6,700


4236




Ordinary


Sale


1,400


4154




Ordinary


Sale


800


4151




Ordinary


Sale


100


4150




Ordinary


Sale


100


4150




Ordinary


Sale


500


4150




Ordinary


Sale


1,500


4147




Ordinary


Sale


100


4156




Ordinary


Sale


500


4161




Ordinary


Sale


1,500


4175




Ordinary


Sale


600


4156




Ordinary


Sale


100


4182




Ordinary


Sale


800


4180




Ordinary


Sale


1,400


4181




Ordinary


Sale


300


4174




Ordinary


Sale


200


4172




Ordinary


Sale


300


4173




Ordinary


Sale


100


4172




Ordinary


Sale


300


4174




Ordinary


Sale


400


4173




Ordinary


Sale


200


4169




Ordinary


Sale


1,400


4172




Ordinary


Sale


1,300


4239




Ordinary


Sale


4,100


4179




Ordinary


Sale


500


4149




Ordinary


Sale


1,500


4149




Ordinary


Sale


200


4151




Ordinary


Sale


100


4155




Ordinary


Sale


1,100


4156




Ordinary


Sale


1,500


4154




Ordinary


Sale


100


4155




Ordinary


Sale


19,600


4199.8189








Total Purchases


93,585












Total Sales


113,000







 
 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit JPY

























 
 (c)       Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit JPY





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit JPY




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable) JPY








 
 











4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


YES



 
 



Date of disclosure:


29/11/2018




Contact name:


Olivier Vero




Telephone number:


+44 20 7676 6969



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk             




SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
1.         KEY INFORMATION
 



Full name of person making disclosure:


SOCIETE GENERALE SA




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Takeda Pharmaceutical CO LTD



 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 
 



Class of relevant security


Product description e.g. call option


Written or purchased


Number of securities to which option or derivative relates


Exercise price per unit


Type


Expiry date




JPY


e.g. American, European etc.




Ordinary


OTC put-option


Sale


15,700


4707


European options


14/12/2018




Ordinary


OTC put-option


Sale


30,000


5075.10


European options


14/12/2018




Ordinary


OTC put-option


Sale


29,600


5073.65


European options


14/12/2018




Ordinary


OTC put-option


Sale


15,500


4491.40


European options


14/12/2018




Ordinary


OTC put-option


Sale


30,700


4533.90


European options


14/12/2018




Ordinary


Listed call-option


Sale


125,000


5500


European options


13/06/2019




Ordinary


OTC call-option


Sale


131,000


4,600


European options


13/12/2018



 
 
 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 



Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 



 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
 
The currency of all prices and other monetary amounts should be stated.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETPGGWGGUPRGUB